A weed that grows between sidewalk cracks became the subject of an extraordinary cancer headline: dandelion root supposedly destroys 95% of cancer cells in just 48 hours. There is a real study behind the number. But there is also a rather important detail missing from its journey across the internet: the cancer cells were growing in laboratory dishes, not inside patients.
A November 2, 2026 Gardening Soul article revisited the claim and cautioned readers against mistaking laboratory experiments for a treatment. We went back to the original paper to see exactly what was measured, what the researchers actually administered, and what remains unknown.
Where the “95% in 48 hours” figure really comes from
In a 2016 paper published in Oncotarget, a Canadian research team led by Pamela Ovadje and colleagues at the University of Windsor and the University of Ottawa exposed cultured human colorectal cancer cells to a water-based dandelion root extract (DRE). The authors reported that the extract triggered programmed cell death in more than 95% of the colon cancer cells within 48 hours under their experimental conditions.
The study used two colorectal cancer cell lines, HCT116 and HT-29, and compared them with a noncancerous colon-cell line. The researchers reported that the normal cells were less affected at tested doses. They also investigated cell-death signaling pathways, including mitochondrial changes and the activation of caspases—proteins involved in cellular self-destruction.
That is meaningful preliminary research. It is not evidence that dandelion root treats 95% of cancers, or that a person drinking tea will eliminate cancer in two days. The percentage describes a result in particular laboratory models, at particular concentrations, using a specially prepared extract.
It was an extract, not a cup of tea
The preparation matters. According to the original paper, researchers froze and ground dried roots, extracted them in boiling water for three hours, filtered the liquid, freeze-dried it, and reconstituted it to a measured laboratory concentration. Their cell experiments used concentrations between 0.5 and 6.0 milligrams per milliliter.
A home-brewed dandelion tea has not been shown to deliver the same active composition, concentration or exposure to a tumor. Digestion, absorption, metabolism and the difficulty of getting active compounds into cancer tissue present further obstacles. Even an apparently selective effect on healthy cells in a dish does not establish safety in human organs.
Nor does the experiment identify one magic ingredient. The authors found a complex mixture that included plant compounds such as lupeol, taraxasterol and related triterpenes. Which components, if any, could become a useful drug—and at what safe dose—remains an open research question.
What about the mice? That part of the story is real, too
To move beyond cells in dishes, the 2016 investigators implanted human colorectal cancer cells into immunocompromised mice. They then compared untreated animals with mice receiving oral dandelion root extract. The researchers reported that tumor growth was reduced by more than 90% in the treated model.
It is an intriguing follow-up, with sharp limitations. The xenograft efficacy experiments involved four mice per group and tumors implanted under the skin. Those are research tools, not human cancers developing in their usual biological environments. A smaller tumor-growth measurement in a mouse experiment is not equivalent to a cancer cure, improved patient survival or a treatment ready for the clinic.
This distinction should sound familiar to readers of our reporting on tumor-eradicating bacteria in mice: the laboratory finding is worth investigating precisely because it still has difficult questions to answer.
The missing chapter: reliable clinical evidence in people
The researchers wrote in 2016 that their preparation had Health Canada approval for Phase I clinical investigation in some blood cancers. But permission to run an early trial is not proof that a treatment works. Later reporting by PolitiFact described difficulties enrolling patients and securing funding.
Most importantly, there is still no established clinical evidence that dandelion root extract reliably shrinks tumors, prolongs survival or cures cancer in humans. Memorial Sloan Kettering Cancer Center describes anticancer findings from cell-line studies and mentions individual case reports, but says clinical trials are needed to determine safety and effectiveness.
Individual stories about a person whose leukemia improved while using dandelion are not controlled trials. Those people may also have received chemotherapy or other medical care, and an observed improvement does not establish what caused it. A 2025 AAP fact-check also distinguished older leukemia laboratory experiments from the 2016 colorectal-cancer study that actually supplied the widely shared percentage.
Why “natural” does not automatically mean safe
Dandelion is a familiar edible plant. The U.S. National Institutes of Health’s National Center for Complementary and Integrative Health considers ordinary food amounts likely safe, but says there is little scientific evidence for dandelion’s health effects and less is known about larger medicinal quantities.
Memorial Sloan Kettering lists possible side effects including heartburn, stomach upset, rash, low blood sugar and diarrhea. It also flags potential interactions with diuretics and with drug-metabolizing enzymes; some risks are based on laboratory or animal evidence rather than established human effects. Preclinical research has also raised questions about estrogenic activity relevant to hormone-sensitive conditions.
For patients receiving cancer treatment, even seemingly harmless supplements deserve scrutiny. The National Cancer Institute warns that herbs and supplements may change how anticancer medications are absorbed, metabolized or eliminated. People in treatment should discuss any botanical extracts or supplements with their oncology team and should not substitute an unproven remedy for recommended care.
So, is the claim true or false?
True in its specific experimental setting: the 2016 researchers reported programmed cell death in more than 95% of certain colon-cancer cells exposed to their prepared extract in vitro over 48 hours.
Unsupported as a human health promise: that result does not establish that dandelion tea kills 95% of cancer in a person’s body, treats all cancer types, or works within 48 hours in patients. Mouse data are promising only as another preclinical step, not as clinical proof.
The wider lesson is not that plants are useless to medicine. Plant-derived molecules have played major roles in drug discovery. The lesson is that a scientific finding becomes dangerous when the words in a dish quietly disappear from the headline.
Could a compound or formulation derived from dandelion eventually inspire a useful cancer therapy? That is a question worth researching. But until controlled human trials answer it, the most consequential distinction remains the one between interesting biology and effective treatment.
Sources and further reading
- Ovadje et al. (2016), Oncotarget: original colorectal cancer cell and mouse study
- Memorial Sloan Kettering: Dandelion — research and safety summary
- NIH NCCIH: Dandelion — usefulness and safety
- National Cancer Institute: interactions between cancer therapy and supplements
- AAP FactCheck (2025): dandelion tea and cancer claims
- Gardening Soul (November 2, 2026): the claim revisited
Editorial note: This article assesses published research and is not medical advice. Apep Bar has not independently reproduced the experiments.
